HonorHealth Research Institute announces first patient dosed with new stroke treatment

HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has announced the first patient dosed with BB-031, an investigational stroke treatment. BB-031 works to target platelets, rather than the clotting proteins usually targeted by stroke treatments, in order to reopen blocked blood vessels in the […] The post HonorHealth Research Institute announces first patient dosed with new stroke treatment appeared first on Pharmafile.

Continue reading →